Home World News Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics... World News Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics with a favourable safety profile By Ogkologos - October 6, 2026 64 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PATHFINDER 2 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Emactuzumab reduces tumour size in patients with tenosynovial giant cell tumours October 27, 2026 For Some Kids with Brain Cancer, Targeted Therapy is Better than... June 29, 2022 Reducing Cancer’s Global Burden: A Conversation with NCI’s Dr. Satish Gopal September 24, 2020 Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and... April 14, 2026 Load more HOT NEWS “Scars are Tattoos with Better Stories” With 3 Years Minimum Follow-Up, Nivolumab Plus Ipilimumab Continues to Provide... Rediscovered Drugs Hit Leukemia from Two Different Angles Targeted Drug Approved for Acute Myeloid Leukemia with IDH1 Gene Mutations
